头孢洛扎/他唑巴坦治疗多重耐药铜绿假单胞菌引起的呼吸道感染 - Suppr

Suppr

超能文献

Ceftolozane/Tazobactam Therapy of Respiratory Infections due to Multidrug-Resistant Pseudomonas aeruginosa.

作者信息

Gelfand Michael S, Cleveland Kerry O

机构信息

Division of Infectious Diseases, Department of Medicine, University of Tennessee Health Science Center, Memphis.

出版信息

Clin Infect Dis. 2015 Sep 1;61(5):853-5. doi: 10.1093/cid/civ411. Epub 2015 May 28.

DOI:10.1093/cid/civ411

PMID:26021991

Abstract

摘要

相似文献

Ceftolozane/Tazobactam Therapy of Respiratory Infections due to Multidrug-Resistant Pseudomonas aeruginosa.

Clin Infect Dis. 2015 Sep 1;61(5):853-5. doi: 10.1093/cid/civ411. Epub 2015 May 28.

Successful treatment of multidrug-resistant Pseudomonas aeruginosa breakthrough bacteremia with ceftolozane/tazobactam.

Infection. 2017 Feb;45(1):115-117. doi: 10.1007/s15010-016-0944-5. Epub 2016 Sep 26.

Ceftolozane-tazobactam for the treatment of ventilator-associated infections by colistin-resistant Pseudomonas aeruginosa.

Rev Esp Quimioter. 2017 Jun;30(3):224-228. Epub 2017 Mar 29.

Successful Use of Ceftolozane-Tazobactam to Treat a Pulmonary Exacerbation of Cystic Fibrosis Caused by Multidrug-Resistant Pseudomonas aeruginosa.

Pharmacotherapy. 2016 Oct;36(10):e154-e159. doi: 10.1002/phar.1825. Epub 2016 Sep 1.

Salvage Therapy with Ceftolozane-Tazobactam for Multidrug-Resistant Pseudomonas aeruginosa Infections.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). doi: 10.1128/AAC.02136-16. Print 2017 Mar.

Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy.

J Antimicrob Chemother. 2017 Sep 1;72(9):2678-2679. doi: 10.1093/jac/dkx172.

Ceftolozane-tazobactam therapy for multidrug-resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies and hematopoietic-cell transplant recipients.

Infection. 2018 Jun;46(3):431-434. doi: 10.1007/s15010-018-1125-5. Epub 2018 Feb 19.

Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance.

Clin Infect Dis. 2017 Jul 1;65(1):110-120. doi: 10.1093/cid/cix182.

Successful treatment of three severe MDR or XDR Pseudomonas aeruginosa infections with ceftolozane/tazobactam.

Future Microbiol. 2017 Nov;12:1323-1326. doi: 10.2217/fmb-2017-0018. Epub 2017 Oct 5.

Comparison of Ceftolozane-Tazobactam to Traditional Beta-Lactams and Ceftolozane-Tazobactam as an Alternative to Combination Antimicrobial Therapy for Pseudomonas aeruginosa.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.01350-17. Print 2017 Dec.

引用本文的文献

Weighing the Odds: Novel β-Lactam/β-Lactamase Inhibitor Use in Hospital-Acquired and Ventilator-Associated Pneumonia for Patients Who Are Morbidly Obese.

Open Forum Infect Dis. 2023 Aug 28;10(9):ofad454. doi: 10.1093/ofid/ofad454. eCollection 2023 Sep.

Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USA.

JAC Antimicrob Resist. 2023 Jan 2;5(1):dlac131. doi: 10.1093/jacamr/dlac131. eCollection 2023 Feb.

Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study).

Microbiol Spectr. 2022 Jun 29;10(3):e0229221. doi: 10.1128/spectrum.02292-21. Epub 2022 Apr 27.

An Evidence-Based Multidisciplinary Approach Focused on Creating Algorithms for Targeted Therapy of Infection-Related Ventilator-Associated Complications (IVACs) Caused by and in Critically Ill Adult Patients.

Antibiotics (Basel). 2021 Dec 28;11(1):33. doi: 10.3390/antibiotics11010033.

Systematic Literature Review of Real-world Evidence of Ceftolozane/Tazobactam for the Treatment of Respiratory Infections.

Infect Dis Ther. 2021 Sep;10(3):1227-1252. doi: 10.1007/s40121-021-00491-x. Epub 2021 Jul 18.

Ceftolozane/Tazobactam for Resistant Drugs Respiratory Infections: A Systematic Literature Review of the Real-World Evidence.

Life (Basel). 2021 May 24;11(6):474. doi: 10.3390/life11060474.

Multidrug resistant bacteremia in hematopoietic stem cell transplant recipients.

Tunis Med. 2021 Feb;99(2):269-276.

Real-world use of ceftolozane/tazobactam: a systematic literature review.

Antimicrob Resist Infect Control. 2021 Apr 8;10(1):68. doi: 10.1186/s13756-021-00933-8.

Molecular Characterization of Baseline and Pseudomonas aeruginosa Isolates from a Phase 3 Nosocomial Pneumonia (ASPECT-NP) Clinical Trial.

Antimicrob Agents Chemother. 2021 Feb 17;65(3). doi: 10.1128/AAC.02461-20.

New cephalosporins for the treatment of pneumonia in internal medicine wards.

J Thorac Dis. 2020 Jul;12(7):3747-3763. doi: 10.21037/jtd-20-417.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验